AprilBio Co (XKRX:397030) Total Liabilities : ₩8,611 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is AprilBio Co Total Liabilities?

AprilBio Co's Total Liabilities for the quarter that ended in Dec. 2024 was ₩8,611 Mil.

AprilBio Co's quarterly Total Liabilities increased from Jun. 2024 (₩22,158.94 Mil) to Sep. 2024 (₩22,298.05 Mil) but then declined from Sep. 2024 (₩22,298.05 Mil) to Dec. 2024 (₩8,610.82 Mil).

AprilBio Co's annual Total Liabilities increased from Dec. 2022 (₩1,903.05 Mil) to Dec. 2023 (₩21,954.29 Mil) but then declined from Dec. 2023 (₩21,954.29 Mil) to Dec. 2024 (₩8,610.82 Mil).

AprilBio Co Total Liabilities Historical Data

The historical data trend for AprilBio Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AprilBio Co Total Liabilities Chart

AprilBio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

33,187.37

4,210.96

1,903.05

21,954.29

8,610.82

AprilBio Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial													21,954.29	22,020.56	22,158.94	22,298.05	8,610.82

AprilBio Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

AprilBio Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8482.192	+	(101.847	+	26.782000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	8,611

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	99598.583	-	90987.762
	=	8,611

AprilBio Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8482.192	+	(101.847	+	26.782000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	8,611

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	99598.583	-	90987.762
	=	8,611

AprilBio Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of AprilBio Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

AprilBio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AprilBio Co Ltd (XKRX:397030) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Kangwon National University Road, B-602, College of Medical and Life Sciences, Kangwon National University, Gangwon Special Self-Governing Province, Chuncheon-si, KOR

Website

http://www.aprilbio.com

AprilBio Co Ltd is a bio company is developing biologis. It owns long acting protein medicine platform technology utilizing human FAB antobody parts that makes unusual combination to serum akbumin and EX 12 helper phase antibody library technology.

AprilBio Co Headlines

No Headlines